The development of bioanalytical devices that are portable, compatible, scalable and reliable is critical to effective biodefense at the point-of -care. In addition, clinical data must be generated and incorporated into the key operational decision-maker networks. Cambridge Healthtech’s 26th International Biodetection Technologies: Point-of-Care for Biodefense will bring together the global industry, academic and government biodefense community to discuss advancements in approaches for optimizing performance of field technologies, translational challenges, regulatory approval of diagnostic tools, and data analysis to enable effective decision-making.

Preliminary Agenda


Advances in Fieldable Technologies and Assays

Rapid Point-of-Care Diagnostics for Biosurveillance

Harshini Mukundan, PhD, Team Leader, Chemistry Division, Los Alamos National Laboratory

Agro-Defense - A Holistic, All of Enterprise Approach

Tammy R. Beckham, D.V.M., PhD, Dean, Professor, College of Veterinary Medicine, Kansas State University


Optimizing Performance of Traditional Point-Of-Care Detection

The Application of Point-of-Care Laboratory Testing for Pathogen Detection and Patient Management

Kent Lewandrowski, PhD, Director of Clinical Laboratories, Pathology, Massachusetts General Hospital

Integrated Droplet Based Microfluidic Platform for Rapid Antimicrobial Susceptibility Testing and Bacterial Growth Analysis

Tania Konry, PhD, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University

Technological and Scientific Gaps in Biosurveillance and BioDetection

David R. Hodge, PhD, Program Manager, Chemical Biological Defense Division, U.S. Department of Homeland Security (DHS)


Next Generation Resources for Biodetection at the Point-of-Care

Resources for Point-of-Care Developers: Technology Watch Database

Joany Jackman, PhD, Senior Scientist, Johns Hopkins University Applied Physics Laboratory


Tools and Technologies at the Point-of-Care

Radiation Biodosimetry: A Mass Screening Tool for Radiological/Nuclear Events

Mary Sproull, PhD, Biologist, National Institutes of Health, National Cancer Institute

Digital Assay Solutions and Global Spatiotemporal Surveillance System

Onur Mudanyali, PhD, Director, Engineering, Cellmic

Immune Profiling to Identify Exposure to Infectious Agents

Richard DiPaolo, PhD, Associate Professor, Molecular Microbiology & Immunology, Saint Louis University School of Medicine




For more details on the meeting, or to submit a proposal for presenting, please contact the conference organizing committee:

Craig Wohlers
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-6260
Email: cwohlers@healthtech.com

For sponsorship and exhibit sales information, please contact:
Sherry Johnson
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1359
Email: sjohnson@healthtech.com